Untap Health is a technology company.
Untap Health has raised $2.0M across 1 funding round.
Untap Health has raised $2.0M in total across 1 funding round.
Untap Health has raised $2.0M in total across 1 funding round.
Untap Health's investors include Newland Syndicate, Alex Payne.
Untap Health is a London-based technology company developing wastewater surveillance systems that use PCR technology to detect infectious diseases like COVID-19, flu, RSV, and norovirus in real-time from sewage, before symptoms appear[1][2][3]. It serves organizations in sectors including offices, care homes, hospitals, schools, cruise ships, hospitality, airports, agriculture, and public health agencies, solving the problem of slow, expensive individual testing by providing early warnings for proactive interventions that reduce transmission, absenteeism, and healthcare costs[2][3][5]. The company has raised over $1M in funding, is backed by SOSV, and reports strong growth momentum with a pipeline exceeding 1,500 customer sites in human health, shifting focus to scaling hardware deployment in 2025 for market domination via patented tech and data moats[2][4].
Untap Health was co-founded in early 2021 by Dr. Claire Trant and Dr. Jay Bullen, who met at Entrepreneur First accelerator[3]. Trant, with a PhD in aerospace engines from work with Rolls-Royce, pivoted to water tech regulation amid the COVID-19 devastation of commercial aerospace, while Bullen holds a PhD in water chemistry focused on pharmaceutical detection in water[3][5]. The idea emerged from pandemic-driven interest in wastewater epidemiology; initially targeting city-scale monitoring, they prototyped faster real-time data capabilities, spotting opportunities for on-site use in care homes, offices, and cruise ships, leading to multi-pathogen detection[3][5]. Early traction included real-world hardware testing, R&D tax credits via EmpowerRD, and SOSV investment, humanizing their mission to disrupt passive illness acceptance[1][5].
Untap rides the post-COVID trend in wastewater epidemiology, amplified by needs for proactive health in vulnerable settings amid rising immunocompromised populations (40% lifetime risk) and multi-pathogen threats[1][3]. Timing aligns with government COVID surveillance sparking private adoption, where traditional testing fails on cost, speed, and participation, positioning Untap in a burgeoning market for community-level monitoring across education, healthcare, and hospitality[2][3]. Favorable forces include PCR's reliability, hardware scalability, and data network effects for outbreak prediction, influencing ecosystems by enabling "health autonomy" for organizations and potential public health mapping[1][4].
Untap is primed for 2025 human health ramp-up across 1,500+ sites, leveraging hardware patents and data to dominate UK markets before global expansion, potentially creating real-time national virus maps by 2026[4]. Trends like AI-enhanced analytics, multi-pathogen expansion, and climate-driven disease risks will shape growth, evolving Untap from startup innovator to ecosystem leader in preventive health surveillance. This positions them to turn sewage data into the new norm for safer workplaces and communities, fulfilling their origin vision of containing today's illnesses and tomorrow's pandemics[1][6].
Untap Health has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2022 | $2.0M Seed | Newland Syndicate, Alex Payne |